Best Practice in Phase IV Clinical & Observational Research

Summary

Phase IV clinical trials are one the fastest growing areas of clinical research. Such post-marketing studies are becoming increasingly important as regulatory agencies demand more long-term data which proves efficacy, safety and quality. Furthermore, a key driver is the demands of health technology assessors and payers and their need for evidence-based economic data, again over the long-term. However, as post-marketing studies tend to be more commercial in nature, successfully planning and implementing them can be a major challenge, especially in terms of motivating investigators and recruiting patients who may already have access to the latest medications.
This event will be looking moving towards "best-practice" approaches to designing and implementing post-marketing studies.
Why attend:

" Gain access to the latest methodologies and real-life cases in the field
" Explore how market leaders are improving data accuracy
" Balancing conflicting scientific, regulatory & marketing needs
" Learn more about comparative studies and their value for drug safety
" Understand how key figures are affecting future trends and standards
" Meet ethics committees to retrieve the full regulatory / ethical picture
" Find out how phase IV studies & observational research are being outsourced and how industry players are selecting the right partners

Who will benefit:
Pharmaceutical & biotech companies
Vice Presidents, Directors & Managers of: Medical Affairs, Epidemiology, Clinical Development & Operations, Drug Safety, Pharmacovigilance, Data Management, Regulatory Affairs, Clinical Outsourcing
Solution providers
CROs, EDC & Data Management, Clinical Software, Market Access & Health Outcomes Consultancies
Academics & doctors
Epidemiology, Principle Investigators, Primary Care
Government
Ministries of Health, Regulatory & Health Technology Assessment Agencies
To request the full agenda please follow the link:

https://www.nextlevelpharma.com/events/request_agenda/best_practice_in_phase_iv_clinical_observational_research

For Booking Information:
Tel: +421 232 660 382
Fax: +421 232 660 397
Email: erika@nextlevelpharma.com